Triomel
(glucose, lipid emulsion, amino acids & electrolytes)
The Triomel portfolio gives you a broad selection of three-chamber bags with an olive oil-based lipid to meet the unique nutrition needs of each patient.
Not all critically ill patients are the same, and neither are their nutritional requirements. The Triomel portfolio offers a range of central and peripheral formulations to match the individual protein and energy needs of your patients.1-3 Triomel N12 combines a concentrated protein formulation with low glucose content, resulting in the lowest energy to protein ratio currently available in a standardised, three-chamber bag (3CB).2,3,18-23 Triomel contains olive oil, which is rich in long-chain Omega-9 monounsaturated fatty acids (MUFAs), with fewer polyunsaturated fatty acids (PUFAs) than soybean and fish oil.26 An olive oil-based lipid emulsion may preserve immune function and has been associated with fewer infections than soybean oil.4,10-12
Triomel- meeting the unique nutritional needs of each patient
Prescribe to preserve
Triomel contains an olive oil-based lipid emulsion, which is associated with fewer infections and may preserve immune function.4,10-12
Reach protein targets with less fluid
Triomel N12 contains Clinoleic, an olive oil-based lipid emulsion that has the lowest soy content and may help to reduce infections.2,3,18-23
Low glucose to minimise impact on glycemic control
Hyperglycemia occurs frequently in critically ill patients, which is associated with an increased risk of infection. Triomel N12 has only 73g/L of glucose making it one of the lowest available on the market.
The power of protein
When compared to standard intake, higher protein as prescribed by guidelines was associated with significant clinical improvements in ICU patients.24 A higher and earlier intake of protein has proven to be beneficial in wound healing, hormonal regulation, and cell signaling and was significantly associated with lower mortality as illustrated by a one percent reduction in mortality for every gram of daily protein ingested.7,25
Association of protein intake with 60-day mortality25
Browse the Triomel portfolio
How to activate an Triomel bag
Learn more about Clinical Nutrition
Related Products
ADVERSE EVENT REPORTING
Adverse Events and any drug or medical device product quality complaints (including suspected defective medicines or medical device adverse incidents) should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse Events should also be reported to Baxter Healthcare Ltd, by email ([email protected]) or by phone (+44 (0)1635 206360).Drug or medical device product quality complaints relating to Baxter products can be reported directly to Baxter Healthcare Ltd by email ([email protected]) or by phone (+44 (0)1604 704603).